Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 10298: Comparative Outcomes of Transcatheter Tricuspid Edge-to-Edge Repair versus Transcatheter Tricuspid Valve Replacement: A Propensity-Matched Real-World Analysis

Background: Transcatheter therapies for severe tricuspid regurgitation (TR) have rapidly expanded, with transcatheter tricuspid edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR) emerging as major treatment strategies. Comparative real-world outcome data between these approaches remain...

Kellen J. Round, A. Nouri, R. Rossi et al. · 0 citations
Nov 2026

Abstract 6899: Lipoprotein(a) and Residual Vascular Risk Among Patients Achieving Optimal LDL-C: A Real-World Cohort Analysis

Background: Elevated lipoprotein(a) [Lp(a)] is a heritable, independent risk factor for atherosclerotic cardiovascular disease, and it is not meaningfully reduced by statins or ezetimibe. Whether elevated Lp(a) translates into measurable residual cardiovascular and limb ischemic risk in patients who have achieved an...

Maryam Mojarrad Sani, A. Nouri, Ashkan Abdollahi et al. · 0 citations
Open access Oct 2026

Prasugrel-, ticagrelor-, or clopidogrel-based dual antiplatelet therapy after acute coronary syndrome: a frequentist network meta-analysis

Dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 receptor inhibitor (P2Y12i), remains the cornerstone of secondary prevention of thrombotic complications after acute coronary syndrome (ACS). However, the optimal P2Y12i to use as part of DAPT in patients with ACS remains uncertain. We aimed...

M. Joseph, Mrinal Murali Krishna, X. Jacquemyn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.